---
title: 'Review: Opportunities and barriers for omics-based biomarker discovery in
  steatotic liver diseases'
date: '2024-03-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38552880/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240330180641&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The rising prevalence of liver diseases related to obesity and excessive
  use of alcohol is fuelling an increasing demand for accurate biomarkers aimed at
  community screening, diagnosis of steatohepatitis and significant fibrosis, monitoring,
  prognosis and prediction of treatment efficacy. Breakthroughs in omics methodologies
  and the power of bioinformatics have created an excellent opportunity to combine
  clinical needs with technological advancements. Omics technologies allow for ...
disable_comments: true
---
The rising prevalence of liver diseases related to obesity and excessive use of alcohol is fuelling an increasing demand for accurate biomarkers aimed at community screening, diagnosis of steatohepatitis and significant fibrosis, monitoring, prognosis and prediction of treatment efficacy. Breakthroughs in omics methodologies and the power of bioinformatics have created an excellent opportunity to combine clinical needs with technological advancements. Omics technologies allow for ...